Emilia Salzmann-Manrique
Overview
Explore the profile of Emilia Salzmann-Manrique including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bakhtiar S, Kaffenberger C, Salzmann-Manrique E, Donhauser S, Lueck L, Karaca N, et al.
J Autoimmun
. 2022 Sep;
132:102891.
PMID: 36113303
Background: Immune dysregulation as a result of an inborn error of immunity (IEI) leads to the complicated symptoms of refractory multi-organ immune dysregulation. B lymphocytes with immune regulatory capacity (Breg)...
12.
Schmidt A, Orlowski A, Salzmann-Manrique E, Konigs C
EJHaem
. 2022 Jul;
2(4):805-808.
PMID: 35845215
No abstract available.
13.
Bexte T, Alzubi J, Reindl L, Wendel P, Schubert R, Salzmann-Manrique E, et al.
Oncoimmunology
. 2022 Jun;
11(1):2081415.
PMID: 35694192
Natural Killer (NK) cells are known for their high intrinsic cytotoxic capacity, and the possibility to be applied as 'off-the-shelf' product makes them highly attractive for cell-based immunotherapies. In patients...
14.
Gotta J, Bielack S, Hecker-Nolting S, Sorg B, Kevric M, Salzmann-Manrique E, et al.
Klin Padiatr
. 2021 Dec;
234(3):154-162.
PMID: 34902872
Background: Increasing numbers of patients surviving malignant bone tumors around the knee joint have led to an increasing importance to investigate long-term results. This study assessed the long-term results of...
15.
Barnbrock A, Salzmann-Manrique E, Sanger N, Fiegel H, Ochsendorf F, Klingebiel T, et al.
Ann Hematol
. 2021 Sep;
100(11):2831-2841.
PMID: 34536088
Since the survival rates of pediatric patients undergoing cancer treatment or hematopoietic stem cell transplantation (HSCT) have increased rapidly in recent decades, the late effects of treatment are now an...
16.
Bakhtiar S, Salzmann-Manrique E, Donath H, Woelke S, Duecker R, Fritzemeyer S, et al.
Br J Haematol
. 2021 Aug;
194(5):879-887.
PMID: 34337741
Ataxia-telangiectasia (A-T) is a hereditary immune system disorder with neurodegeneration. Its first neurologic symptoms include ataxic gait in early childhood, with slowly progressive cerebellar ataxia, oculomotor apraxia, oculocutaneous telangiectasia, and...
17.
Bakhtiar S, Salzmann-Manrique E, Blok H, Eikema D, Hazelaar S, Ayas M, et al.
Blood Adv
. 2021 Feb;
5(1):262-273.
PMID: 33570653
Type I and III leukocyte adhesion deficiencies (LADs) are primary immunodeficiency disorders resulting in early death due to infections and additional bleeding tendency in LAD-III. The curative treatment of LAD-I...
18.
Schmedding A, Wittekind B, Salzmann-Manrique E, Schloesser R, Rolle U
Pediatr Surg Int
. 2020 Mar;
36(5):569-578.
PMID: 32219563
Purpose: Neonatal surgery for abdominal wall defects is not performed in a centralized manner in Germany. The aim of this study was to investigate whether treatment for abdominal wall defects...
19.
Kuci Z, Jordan C, Wehner S, Sorensen J, Jarisch A, Salzmann-Manrique E, et al.
Cells
. 2020 Feb;
9(2).
PMID: 32059574
As the biology of mesenchymal stromal cells (MSCs) in patients with non-malignant hematological diseases (NMHD) is poorly understood, in the current study we performed a basic characterization of the phenotype...
20.
Bonig H, Kuci Z, Kuci S, Bakhtiar S, Basu O, Bug G, et al.
Cells
. 2019 Dec;
8(12).
PMID: 31817480
(1) Background: Refractory acute graft-versus-host disease (R-aGvHD) remains a leading cause of death after allogeneic stem cell transplantation. Survival rates of 15% after four years are currently achieved; deaths are...